A311690 Stock Overview
Provides microbiome research solutions to companies, hospitals, and individuals in the healthcare field in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
CJ Bioscience, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩11,950.00 |
| 52 Week High | ₩17,500.00 |
| 52 Week Low | ₩11,270.00 |
| Beta | 1.0 |
| 11 Month Change | 1.10% |
| 3 Month Change | -12.39% |
| 1 Year Change | -26.10% |
| 33 Year Change | -72.08% |
| 5 Year Change | n/a |
| Change since IPO | -68.96% |
Recent News & Updates
Shareholder Returns
| A311690 | KR Healthcare Services | KR Market | |
|---|---|---|---|
| 7D | -4.8% | -9.2% | -4.2% |
| 1Y | -26.1% | -62.8% | -2.7% |
Return vs Industry: A311690 exceeded the KR Healthcare Services industry which returned -62.8% over the past year.
Return vs Market: A311690 underperformed the KR Market which returned -2.7% over the past year.
Price Volatility
| A311690 volatility | |
|---|---|
| A311690 Average Weekly Movement | 4.7% |
| Healthcare Services Industry Average Movement | 8.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A311690 has not had significant price volatility in the past 3 months.
Volatility Over Time: A311690's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 137 | n/a | www.cjbioscience.com |
CJ Bioscience, Inc. provides microbiome research solutions to companies, hospitals, and individuals in the healthcare field in South Korea and internationally. Its solutions include TrueBac ID, a cloud analysis platform for the identification of microorganism; and EzBioCloud, a public data and analytics portal that offers taxonomy, ecology, genomics, metagenomics, and microbiome of bacteria and archaea. The company also provides Smilegut, a smile intestinal microbial monitoring service; and Smilebaby, a customized healthcare service, which offers information on the growth of infants based on the intestinal microflora.
CJ Bioscience, Inc. Fundamentals Summary
| A311690 fundamental statistics | |
|---|---|
| Market cap | ₩108.89b |
| Earnings (TTM) | -₩21.17b |
| Revenue (TTM) | ₩4.90b |
22.2x
P/S Ratio-5.1x
P/E RatioIs A311690 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A311690 income statement (TTM) | |
|---|---|
| Revenue | ₩4.90b |
| Cost of Revenue | ₩3.69b |
| Gross Profit | ₩1.21b |
| Other Expenses | ₩22.38b |
| Earnings | -₩21.17b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.32k |
| Gross Margin | 24.75% |
| Net Profit Margin | -432.06% |
| Debt/Equity Ratio | 9.1% |
How did A311690 perform over the long term?
See historical performance and comparison